02/23/2021
https://congress.gov...
"The cost of prescription drugs is way too high."
"CREATES addresses a tactic the company that makes Revlimid, Celgene, uses to deny generic companies access to samples of Revlimid."
"Some on the other side of the aisle... feel that these high drug prices represent a failure of markets, a failure of capitalism."
"You developed that product, and when you developed that product and started marketing that product, did you follow the law?"